Elicio Therapeutics prices $11.5M public offering of common stock and warrants

Elicio Therapeutics, Inc.

Gross proceeds ~$11.5M; net proceeds ~$10.9M after discounts and expenses.
Offering consists of 500K shares and 1.8M pre-funded warrants, each with common warrants exercisable at $5.00 for 5 years.
Combined price: $5.00 per share+common warrant; $4.99 per pre-funded warrant+common warrant.
Expected to close July 1, 2024; proceeds to advance development pipeline and for working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.